PerkinElmer to Acquire RHS for $0.28/Share

Charles Gross , Benzinga Staff Writer February 25, 2018 5:47pm RHS Limited (ASX: RHS)  is pleased to announce that it has entered into a binding Scheme Implementation Agreement (“SIA”) with PerkinElmer, Inc. (“PerkinElmer”) PKI 0.29% for the acquisition by PerkinElmer of all of the issued share capital of RHS by way of a Scheme of Arrangement (“Scheme”) for $0.28 per share. The... Read more

Announcing the 2018 Lee Osheroff Richardson Science Prize Winner

20 February 2018 Oxford Instruments is delighted to announce the winner of the 2018 Lee Osheroff Richardson (LOR) Science Prize for North and South America as Dr Kate A. Ross, Assistant Professor, Department of Physics of Colorado State University, USA. Dr Ross is recognized for her research towards elucidation of exotic magnetic ground states and... Read more

The VERITY 3011 Isocratic Pump Achieves Nearly Pulse-free Flow Rates for Improved Efficiency

Middleton, WI (February 15, 2018) – Gilson, an industry leader in liquid handling, purification, and extraction laboratory instruments, announces an expansion to its chromatography systems product offering with the introduction of the VERITY® 3011 Isocratic Pump. The new VERITY 3011 Pump broadens the depth of the VERITY purification systems portfolio with advancements over existing pumps including a... Read more

Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Next-Generation Sequencing

Download PDF SAN FRANCISCO, Calif. – February 14, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the commercial availability of several new products to enhance next-generation sequencing including its Twist Human Core Exome Kit, an innovative and comprehensive library preparation and target enrichment kit,... Read more

10x Genomics Announces New Partnership Programs

–New Certified Service Provider and Compatible Partnership Programs will provide an extended ecosystem of reliable NGS workflow solutions for 10x Genomics’ customers– PLEASANTON, CA.—February 12, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced a global partnership ecosystem to accelerate customer adoption of 10x Genomics’ sequencing applications through the Certified Service Provider... Read more

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Location: Cambridge 12/02/2018 Horizon out-licenses proprietary cell line and Helitron transposon gene editing technologies demonstrating Horizon’s ability to generate revenues from internally derived IP Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic... Read more

10x Genomics joins EMBL’s Corporate Partnership Program

–Joining forces for single-cell research excellence– PLEASANTON, CA.—February 21, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions. “As a leader in single cell genomics, 10x Genomics is investing in... Read more